Thomas Sciascia
Fondateur chez TREVI THERAPEUTICS, INC.
Fortune : 529 455 $ au 30/04/2024
Postes actifs de Thomas Sciascia
Sociétés | Poste | Début | Fin |
---|---|---|---|
TREVI THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/03/2011 | - |
Fondateur | 01/01/2011 | - |
Historique de carrière de Thomas Sciascia
Anciens postes connus de Thomas Sciascia
Sociétés | Poste | Début | Fin |
---|---|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/01/2000 | 01/01/2001 |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/01/1997 | 01/01/2000 |
Boston University | Corporate Officer/Principal | 01/01/1983 | 01/01/1997 |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Directeur Technique/Scientifique/R&D | 01/03/2001 | - |
Formation de Thomas Sciascia
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Israël | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 4 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
TREVI THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
- Bourse
- Insiders
- Thomas Sciascia
- Expérience